FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2959398003> ?p ?o ?g. }

• W2959398003 endingPage "1666" @default.
• W2959398003 startingPage "1652" @default.
• W2959398003 abstract "Objective: We examined the pathogenic significance of VEGF (vascular endothelial growth factor)-A in experimental abdominal aortic aneurysms (AAAs) and the translational value of pharmacological VEGF-A or its receptor inhibition in aneurysm suppression. Approaches and Results: AAAs were created in male C57BL/6J mice via intra-aortic elastase infusion. Soluble VEGFR (VEGF receptor)-2 extracellular ligand-binding domain (delivered in Ad [adenovirus]-VEGFR-2), anti–VEGF-A mAb (monoclonal antibody), and sunitinib were used to sequester VEGF-A, neutralize VEGF-A, and inhibit receptor tyrosine kinase activity, respectively. Influences on AAAs were assessed using ultrasonography and histopathology. In vitro transwell migration and quantitative reverse transcription polymerase chain reaction assays were used to assess myeloid cell chemotaxis and mRNA expression, respectively. Abundant VEGF-A mRNA and VEGF-A–positive cells were present in aneurysmal aortae. Sequestration of VEGF-A by Ad-VEGFR-2 prevented AAA formation, with attenuation of medial elastolysis and smooth muscle depletion, mural angiogenesis and monocyte/macrophage infiltration. Treatment with anti–VEGF-A mAb prevented AAA formation without affecting further progression of established AAAs. Sunitinib therapy substantially mitigated both AAA formation and further progression of established AAAs, attenuated aneurysmal aortic MMP2 (matrix metalloproteinase) and MMP9 protein expression, inhibited inflammatory monocyte and neutrophil chemotaxis to VEGF-A, and reduced MMP2, MMP9, and VEGF-A mRNA expression in macrophages and smooth muscle cells in vitro. Additionally, sunitinib treatment reduced circulating monocytes in aneurysmal mice. Conclusions: VEGF-A and its receptors contribute to experimental AAA formation by suppressing mural angiogenesis, MMP and VEGF-A production, myeloid cell chemotaxis, and circulating monocytes. Pharmacological inhibition of receptor tyrosine kinases by sunitinib or related compounds may provide novel opportunities for clinical aneurysm suppression." @default.
• W2959398003 created "2019-07-23" @default.
• W2959398003 creator A5000229807 @default.
• W2959398003 creator A5003642180 @default.
• W2959398003 creator A5007565424 @default.
• W2959398003 creator A5012888995 @default.
• W2959398003 creator A5022728579 @default.
• W2959398003 creator A5034351013 @default.
• W2959398003 creator A5039487641 @default.
• W2959398003 creator A5039998579 @default.
• W2959398003 creator A5046597133 @default.
• W2959398003 creator A5053087783 @default.
• W2959398003 creator A5056685479 @default.
• W2959398003 creator A5062656088 @default.
• W2959398003 creator A5066732440 @default.
• W2959398003 creator A5069325909 @default.
• W2959398003 creator A5077683891 @default.
• W2959398003 creator A5078982293 @default.
• W2959398003 creator A5085094819 @default.
• W2959398003 creator A5089855616 @default.
• W2959398003 date "2019-08-01" @default.
• W2959398003 modified "2023-10-17" @default.
• W2959398003 title "Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model" @default.
• W2959398003 cites W1600542667 @default.
• W2959398003 cites W1965060586 @default.
• W2959398003 cites W1968114204 @default.
• W2959398003 cites W1974942503 @default.
• W2959398003 cites W1983460561 @default.
• W2959398003 cites W1989090840 @default.
• W2959398003 cites W1989955193 @default.
• W2959398003 cites W1995806381 @default.
• W2959398003 cites W2001112568 @default.
• W2959398003 cites W2018981372 @default.
• W2959398003 cites W2028160054 @default.
• W2959398003 cites W2033665800 @default.
• W2959398003 cites W2041834530 @default.
• W2959398003 cites W2051971528 @default.
• W2959398003 cites W2053221827 @default.
• W2959398003 cites W2053411009 @default.
• W2959398003 cites W2053818693 @default.
• W2959398003 cites W2064399578 @default.
• W2959398003 cites W2080071215 @default.
• W2959398003 cites W2085807137 @default.
• W2959398003 cites W2100712659 @default.
• W2959398003 cites W2103268700 @default.
• W2959398003 cites W2104966898 @default.
• W2959398003 cites W2105669313 @default.
• W2959398003 cites W2105719883 @default.
• W2959398003 cites W2107109383 @default.
• W2959398003 cites W2111653675 @default.
• W2959398003 cites W2111792559 @default.
• W2959398003 cites W2122271737 @default.
• W2959398003 cites W2133547527 @default.
• W2959398003 cites W2135703618 @default.
• W2959398003 cites W2138519685 @default.
• W2959398003 cites W2141761324 @default.
• W2959398003 cites W2142304165 @default.
• W2959398003 cites W2144718958 @default.
• W2959398003 cites W2148994065 @default.
• W2959398003 cites W2153688070 @default.
• W2959398003 cites W2158680134 @default.
• W2959398003 cites W2162902120 @default.
• W2959398003 cites W2168865951 @default.
• W2959398003 cites W2170948443 @default.
• W2959398003 cites W2171684472 @default.
• W2959398003 cites W2172240949 @default.
• W2959398003 cites W2191517484 @default.
• W2959398003 cites W2270786196 @default.
• W2959398003 cites W2282425628 @default.
• W2959398003 cites W2338299575 @default.
• W2959398003 cites W2404741164 @default.
• W2959398003 cites W2414560926 @default.
• W2959398003 cites W2416331198 @default.
• W2959398003 cites W2429056383 @default.
• W2959398003 cites W2464748071 @default.
• W2959398003 cites W2484473742 @default.
• W2959398003 cites W2486397717 @default.
• W2959398003 cites W2519342050 @default.
• W2959398003 cites W2529609982 @default.
• W2959398003 cites W2567762258 @default.
• W2959398003 cites W2606821969 @default.
• W2959398003 cites W2775264975 @default.
• W2959398003 cites W2781838311 @default.
• W2959398003 cites W2782896126 @default.
• W2959398003 cites W2787002821 @default.
• W2959398003 doi "https://doi.org/10.1161/atvbaha.119.312497" @default.
• W2959398003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6699755" @default.
• W2959398003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31294623" @default.
• W2959398003 hasPublicationYear "2019" @default.
• W2959398003 type Work @default.
• W2959398003 sameAs 2959398003 @default.
• W2959398003 citedByCount "44" @default.
• W2959398003 countsByYear W29593980032020 @default.
• W2959398003 countsByYear W29593980032021 @default.
• W2959398003 countsByYear W29593980032022 @default.
• W2959398003 countsByYear W29593980032023 @default.
• W2959398003 crossrefType "journal-article" @default.
• W2959398003 hasAuthorship W2959398003A5000229807 @default.

• next